Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 55 articles:
HTML format
Text format



Single Articles


    April 2018
  1. CHEN N, Feng L, Qu H, Lu K, et al
    Overexpression of IL-9 induced by STAT3 phosphorylation is mediated by miR-155 and miR-21 in chronic lymphocytic leukemia.
    Oncol Rep. 2018 Apr 12. doi: 10.3892/or.2018.6367.
    PubMed     Text format     Abstract available


    February 2018
  2. MA X, Zhou X, Qu H, Ma Y, et al
    TRIB2 knockdown as a regulator of chemotherapy resistance and proliferation via the ERK/STAT3 signaling pathway in human chronic myelogenous leukemia K562/ADM cells.
    Oncol Rep. 2018 Feb 7. doi: 10.3892/or.2018.6249.
    PubMed     Text format     Abstract available


  3. DONG L, Xu WW, Li H, Bi KH, et al
    In vitro and in vivo anticancer effects of marmesin in U937 human leukemia cells are mediated via mitochondrial-mediated apoptosis, cell cycle arrest, and inhibition of cancer cell migration.
    Oncol Rep. 2018;39:597-602.
    PubMed     Text format     Abstract available


    January 2018
  4. LI GY, Liu JZ, Zhang L, Liu GZ, et al
    Knockdown of immature colon carcinoma transcript 1 induces suppression of proliferation, S-phase arrest and apoptosis in leukemia cells.
    Oncol Rep. 2018 Jan 3. doi: 10.3892/or.2018.6185.
    PubMed     Text format     Abstract available


  5. LEE KW, Um ES, Jung BB, Choi ES, et al
    Rhus verniciflua Stokes extract induces inhibition of cell growth and apoptosis in human chronic myelogenous leukemia K562 cells.
    Oncol Rep. 2018 Jan 3. doi: 10.3892/or.2018.6179.
    PubMed     Text format     Abstract available


    December 2017
  6. LIN MW, Yang JS, Lu CC, Lin C, et al
    2-Phenyl-4-quinolone (YT-1) induces G2/M phase arrest and an intrinsic apoptotic mechanism in human leukemia cells.
    Oncol Rep. 2017 Dec 20. doi: 10.3892/or.2017.6170.
    PubMed     Text format     Abstract available


    November 2017
  7. YANG JS, Lee CY, Cho HC, Lu CC, et al
    ITR284 modulates cell differentiation in human chronic myelogenous leukemia K562 cells.
    Oncol Rep. 2017 Nov 9. doi: 10.3892/or.2017.6090.
    PubMed     Text format     Abstract available


    September 2017
  8. SHEN Y, Liu Q, Lou S, Luo Y, et al
    Decreased expression of the augmenter of liver regeneration results in growth inhibition and increased chemosensitivity of acute T lymphoblastic leukemia cells.
    Oncol Rep. 2017 Sep 21. doi: 10.3892/or.2017.5984.
    PubMed     Text format     Abstract available


    July 2017
  9. HUANG JL, Liu W, Tian LH, Chai TT, et al
    Upregulation of long non-coding RNA MALAT-1 confers poor prognosis and influences cell proliferation and apoptosis in acute monocytic leukemia.
    Oncol Rep. 2017 Jul 10. doi: 10.3892/or.2017.5802.
    PubMed     Text format     Abstract available


    June 2017
  10. HAN XJ, Shi SL, Wei YF, Jiang LP, et al
    Involvement of mitochondrial dynamics in the antineoplastic activity of cisplatin in murine leukemia L1210 cells.
    Oncol Rep. 2017 Jun 28. doi: 10.3892/or.2017.5765.
    PubMed     Text format     Abstract available


  11. JI Y, Ma Y, Chen X, Ji X, et al
    Microvesicles released from human embryonic stem cell derived-mesenchymal stem cells inhibit proliferation of leukemia cells.
    Oncol Rep. 2017 Jun 16. doi: 10.3892/or.2017.5729.
    PubMed     Text format     Abstract available


  12. LIU Y, Shin DY, Oh S, Kim S, et al
    KML001 and doxercalciferol induce synergistic antileukemic effect in acute lymphoid leukemia cells.
    Oncol Rep. 2017 Jun 1. doi: 10.3892/or.2017.5688.
    PubMed     Text format     Abstract available


  13. KONG X, Luo J, Xu T, Zhou Y, et al
    Plumbagin enhances TRAIL-induced apoptosis of human leukemic Kasumi1 cells through upregulation of TRAIL death receptor expression, activation of caspase-8 and inhibition of cFLIP.
    Oncol Rep. 2017;37:3423-3432.
    PubMed     Text format     Abstract available


  14. KIM DM, Jang H, Shin MG, Kim JH, et al
    beta-catenin induces expression of prohibitin gene in acute leukemic cells.
    Oncol Rep. 2017;37:3201-3208.
    PubMed     Text format     Abstract available


    May 2017
  15. ZHOU HR, Fu HY, Wu DS, Zhang YY, et al
    Relationship between epigenetic changes in Wnt antagonists and acute leukemia.
    Oncol Rep. 2017;37:2663-2671.
    PubMed     Text format     Abstract available


    March 2017
  16. CHEN JR, Jia XH, Wang H, Yi YJ, et al
    With no interaction, knockdown of Apollon and MDR1 reverse the multidrug resistance of human chronic myelogenous leukemia K562/ADM cells.
    Oncol Rep. 2017 Mar 29. doi: 10.3892/or.2017.5535.
    PubMed     Text format     Abstract available


  17. TAO YF, Li ZH, Du WW, Xu LX, et al
    Inhibiting PLK1 induces autophagy of acute myeloid leukemia cells via mammalian target of rapamycin pathway dephosphorylation.
    Oncol Rep. 2017;37:1419-1429.
    PubMed     Text format     Abstract available


  18. LYU X, Li J, Yun X, Huang R, et al
    miR-181a-5p, an inducer of Wnt-signaling, facilitates cell proliferation in acute lymphoblastic leukemia.
    Oncol Rep. 2017;37:1469-1476.
    PubMed     Text format     Abstract available


    February 2017
  19. LI Y, Zhao L, Li N, Miao Y, et al
    miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1.
    Oncol Rep. 2017 Feb 17. doi: 10.3892/or.2017.5464.
    PubMed     Text format     Abstract available


    January 2017
  20. XU T, Yang XQ, Jiang KL, Wang H, et al
    Expression of the promyelocytic leukemia protein without the nuclear localization signal as a novel diagnostic marker for acute promyelocytic leukemia.
    Oncol Rep. 2017 Jan 9. doi: 10.3892/or.2017.5357.
    PubMed     Text format     Abstract available


    December 2016
  21. HUANG X, Qi L, Lu W, Yang G, et al
    miRNA-301a induces apoptosis of chronic myelogenous leukemia cells by directly targeting TIMP2/ERK1/2 and AKT pathways.
    Oncol Rep. 2016 Dec 22. doi: 10.3892/or.2016.5330.
    PubMed     Text format     Abstract available


  22. ZHOU W, Wang S, Ying Y, Zhou R, et al
    miR-196b/miR-1290 participate in the antitumor effect of resveratrol via regulation of IGFBP3 expression in acute lymphoblastic leukemia.
    Oncol Rep. 2016 Dec 15. doi: 10.3892/or.2016.5321.
    PubMed     Text format     Abstract available


    November 2016
  23. BRUNING A, Juckstock J, Kost B, Tsikouras P, et al
    Induction of DNA damage and apoptosis in human leukemia cells by efavirenz.
    Oncol Rep. 2016 Nov 15. doi: 10.3892/or.2016.5243.
    PubMed     Text format     Abstract available


  24. SMAHELOVA J, Kastankova I, Polakova KM, Klamova H, et al
    Expression of genes encoding centrosomal proteins and the humoral response against these proteins in chronic myeloid leukemia.
    Oncol Rep. 2016 Nov 7. doi: 10.3892/or.2016.5226.
    PubMed     Text format     Abstract available


    October 2016
  25. CHEN Y, Zhou Q, Zhang L, Wang R, et al
    Idelalisib induces G1 arrest and apoptosis in chronic myeloid leukemia K562 cells.
    Oncol Rep. 2016 Oct 17. doi: 10.3892/or.2016.5176.
    PubMed     Text format     Abstract available


  26. PARK EY, Kim JI, Leem DG, Shin JS, et al
    Resveratrol analogue (E)-8-acetoxy-2-[2-(3,4-diacetoxyphenyl)ethenyl]-quinazoline induces apoptosis via Fas-mediated pathway in HL-60 human leukemia cells.
    Oncol Rep. 2016 Oct 13. doi: 10.3892/or.2016.5168.
    PubMed     Text format     Abstract available


  27. ZHANG YY, Huang SH, Zhou HR, Chen CJ, et al
    Role of HOTAIR in the diagnosis and prognosis of acute leukemia.
    Oncol Rep. 2016 Oct 4. doi: 10.3892/or.2016.5147.
    PubMed     Text format     Abstract available


  28. PAN GZ, Zhai FX, Lu Y, Fang ZG, et al
    RUNX3 plays an important role in As2O3induced apoptosis and allows cells to overcome MSCmediated drug resistance.
    Oncol Rep. 2016;36:1927-38.
    PubMed     Text format     Abstract available


    September 2016
  29. SHI L, Weng XQ, Sheng Y, Wu J, et al
    Staurosporine enhances ATRA-induced granulocytic differentiation in human leukemia U937 cells via the MEK/ERK signaling pathway.
    Oncol Rep. 2016 Sep 23. doi: 10.3892/or.2016.5123.
    PubMed     Text format     Abstract available


  30. PANAGOPOULOS I, Torkildsen S, Gorunova L, Ulvmoen A, et al
    RUNX1 truncation resulting from a cryptic and novel t(6;21)(q25;q22) chromosome translocation in acute myeloid leukemia: A case report.
    Oncol Rep. 2016 Sep 22. doi: 10.3892/or.2016.5119.
    PubMed     Text format     Abstract available


  31. QIAN L, Zhang W, Lei B, He A, et al
    MicroRNA-101 regulates T-cell acute lymphoblastic leukemia progression and chemotherapeutic sensitivity by targeting Notch1.
    Oncol Rep. 2016 Sep 21. doi: 10.3892/or.2016.5117.
    PubMed     Text format     Abstract available


  32. HAGIHARA M, Iriyama N, Yoshida C, Wakita H, et al
    Association of pleural effusion with an early molecular response in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study.
    Oncol Rep. 2016 Sep 20. doi: 10.3892/or.2016.5110.
    PubMed     Text format     Abstract available


  33. TOMAN O, Kabickova T, Vit O, Fiser R, et al
    Proteomic analysis of imatinib-resistant CML-T1 cells reveals calcium homeostasis as a potential therapeutic target.
    Oncol Rep. 2016;36:1258-68.
    PubMed     Text format     Abstract available


    July 2016
  34. LIN CF, Yang JS, Lin C, Tsai FJ, et al
    CCY-1a-E2 induces G2/M phase arrest and apoptotic cell death in HL-60 leukemia cells through cyclin-dependent kinase 1 signaling and the mitochondria-dependent caspase pathway.
    Oncol Rep. 2016 Jul 25. doi: 10.3892/or.2016.4970.
    PubMed     Text format     Abstract available


  35. YU G, Yin C, Jiang L, Zheng Z, et al
    Amyloid precursor protein cooperates with c-KIT mutation/overexpression to regulate cell apoptosis in AML1-ETO-positive leukemia via the PI3K/AKT signaling pathway.
    Oncol Rep. 2016 Jul 21. doi: 10.3892/or.2016.4963.
    PubMed     Text format     Abstract available


  36. ORGANISTA-NAVA J, Gomez-Gomez Y, Illades-Aguiar B, Leyva-Vazquez MA, et al
    Regulation of the miRNA expression by TEL/AML1, BCR/ABL, MLL/AF4 and TCF3/PBX1 oncoproteins in acute lymphoblastic leukemia (Review).
    Oncol Rep. 2016 Jul 19. doi: 10.3892/or.2016.4948.
    PubMed     Text format     Abstract available


  37. FU C, Gong Y, Shi X, Sun Z, et al
    Plumbagin reduces chronic lymphocytic leukemia cell survival by downregulation of Bcl-2 but upregulation of the Bax protein level.
    Oncol Rep. 2016 Jul 19. doi: 10.3892/or.2016.4950.
    PubMed     Text format     Abstract available


  38. ZENG Y, Weng G, Fan J, Li Z, et al
    Curcumin reduces the expression of survivin, leading to enhancement of arsenic trioxide-induced apoptosis in myelodysplastic syndrome and leukemia stem-like cells.
    Oncol Rep. 2016 Jul 15. doi: 10.3892/or.2016.4944.
    PubMed     Text format     Abstract available


  39. HAN MH, Lee WS, Nagappan A, Kim HJ, et al
    Polyphenols from Korean prostrate spurge Euphorbia supina induce apoptosis through the Fas-associated extrinsic pathway and activation of ERK in human leukemic U937 cells.
    Oncol Rep. 2016;36:99-107.
    PubMed     Text format     Abstract available


  40. CHEN Y, Liu ZH, Xia J, Li XP, et al
    20(S)-ginsenoside Rh2 inhibits the proliferation and induces the apoptosis of KG-1a cells through the Wnt/beta-catenin signaling pathway.
    Oncol Rep. 2016;36:137-46.
    PubMed     Text format     Abstract available


    June 2016
  41. YU Y, Duan S, He J, Liang W, et al
    Highly sensitive detection of leukemia cells based on aptamer and quantum dots.
    Oncol Rep. 2016 Jun 10. doi: 10.3892/or.2016.4866.
    PubMed     Text format     Abstract available


  42. MA D, Jing X, Shen B, Liu X, et al
    Leukemia inhibitory factor receptor negatively regulates the metastasis of pancreatic cancer cells in vitro and in vivo.
    Oncol Rep. 2016 Jun 9. doi: 10.3892/or.2016.4865.
    PubMed     Text format     Abstract available


    April 2016
  43. ZHANG X, Wu C, Xiong W, Chen C, et al
    Knockdown of p54nrb inhibits migration, invasion and TNF-alpha release of human acute monocytic leukemia THP1 cells.
    Oncol Rep. 2016 Apr 20. doi: 10.3892/or.2016.4756.
    PubMed     Text format     Abstract available


  44. WANG H, Jia XH, Chen JR, Wang JY, et al
    Osthole shows the potential to overcome P-glycoproteinmediated multidrug resistance in human myelogenous leukemia K562/ADM cells by inhibiting the PI3K/Akt signaling pathway.
    Oncol Rep. 2016 Apr 4. doi: 10.3892/or.2016.4730.
    PubMed     Text format     Abstract available


  45. NAKAJIMA H, Murakami Y, Morii E, Akao T, et al
    Induction of eEF2-specific antitumor CTL responses in vivo by vaccination with eEF2-derived 9mer-peptides.
    Oncol Rep. 2016;35:1959-66.
    PubMed     Text format     Abstract available


    March 2016
  46. QIAN S, Sun L, Li J, Wu J, et al
    MAP30 inhibits autophagy through enhancing acetyltransferase p300 and induces apoptosis in acute myeloid leukemia cells.
    Oncol Rep. 2016 Mar 24. doi: 10.3892/or.2016.4705.
    PubMed     Text format     Abstract available


  47. CHE Y, Ren X, Xu L, Ding X, et al
    Critical involvement of the alpha(1,2)-fucosyltransferase in multidrug resistance of human chronic myeloid leukemia.
    Oncol Rep. 2016 Mar 11. doi: 10.3892/or.2016.4673.
    PubMed     Text format     Abstract available


  48. PEREZ-FIGUEROA E, Sanchez-Cuaxospa M, Martinez-Soto KA, Sanchez-Zauco N, et al
    Strong inflammatory response and Th1-polarization profile in children with acute lymphoblastic leukemia without apparent infection.
    Oncol Rep. 2016 Mar 7. doi: 10.3892/or.2016.4657.
    PubMed     Text format     Abstract available


    February 2016
  49. MONZEN S, Chiba M, Hosokawa Y
    Genetic network profiles associated with established resistance to ionizing radiation in acute promyelocytic leukemia cells and their extracellular vesicles.
    Oncol Rep. 2016;35:749-756.
    PubMed     Text format     Abstract available


  50. DI STEFANO C, Mirone G, Perna S, Marfe G, et al
    The roles of microRNAs in the pathogenesis and drug resistance of chronic myelogenous leukemia (Review).
    Oncol Rep. 2016;35:614-624.
    PubMed     Text format     Abstract available


    January 2016
  51. YUAN B, Yoshino Y, Fukushima H, Markova S, et al
    Multidrug resistance-associated protein 4 is a determinant of arsenite resistance.
    Oncol Rep. 2016;35:147-54.
    PubMed     Text format     Abstract available


    December 2015
  52. FU C, Gong Y, Shi X, Shi H, et al
    Expression and regulation of COP1 in chronic lymphocytic leukemia cells for promotion of cell proliferation and tumorigenicity.
    Oncol Rep. 2015 Dec 28. doi: 10.3892/or.2015.4526.
    PubMed     Text format     Abstract available


    November 2015
  53. CAO L, Xiao PF, Tao YF, Hu SY, et al
    Microarray profiling of bone marrow long non-coding RNA expression in Chinese pediatric acute myeloid leukemia patients.
    Oncol Rep. 2015 Nov 12. doi: 10.3892/or.2015.4415.
    PubMed     Text format     Abstract available


    July 2015
  54. VAHEDI S, Chueh FY, Dutta S, Chandran B, et al
    Nuclear lymphocyte-specific protein tyrosine kinase and its interaction with CR6-interacting factor 1 promote the survival of human leukemic T cells.
    Oncol Rep. 2015;34:43-50.
    PubMed     Text format     Abstract available


    May 2015
  55. SHIBAYAMA Y, Kondo T, Ohya H, Fujisawa S, et al
    Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients.
    Oncol Rep. 2015;33:2176-82.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: